Skip to main content
Fig. 6 | Cancer Cell International

Fig. 6

From: Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma

Fig. 6

Clinical characteristics of CMGs prognostic signature in different subgroups. A The heatmap and clinicopathological factors of high- and low-risk subgroups. *P < 0.05, **P < 0.01, ***P < 0.001. B The student’s t-test was used to assessed the relationship between the CMGs prognostic signature and age, gender, stage, grade, TMN stage. C Kaplan–Meier survival analyses of CMGs risk model in different clinical subgroups based on age, gender, stage, grade, TMN stage with log-rank test

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us